Healing & Recovery Protocol

Protocol Overview

The Healing & Recovery Protocol is designed to accelerate tissue repair for acute and chronic injuries affecting tendons, ligaments, muscles, and connective tissue. This evidence-based stack combines three synergistic peptides with complementary mechanisms of action.

Primary Goal: Reduce healing time by 30-50% compared to natural recovery

Target Conditions:

• Tendon injuries (Achilles, rotator cuff, tennis elbow)
• Ligament sprains and tears
• Muscle strains and tears
• Post-surgical recovery
• Chronic overuse injuries

Peptide Stack

BPC-157 (Body Protection Compound-157)

Role: Primary healing signalling agent

• Dose: 250-500 mcg
• Frequency: Twice daily (morning and evening)
• Administration: Subcutaneous injection near injury site
• Mechanism: Promotes angiogenesis, upregulates growth hormone receptors, modulates nitric oxide pathways

TB-500 (Thymosin Beta-4)

Role: Systemic tissue regeneration

• Dose: 2-5 mg
• Frequency: Twice weekly
• Administration: Subcutaneous or intramuscular injection
• Mechanism: Promotes cell migration, reduces inflammation, supports new blood vessel formation

GHK-Cu (Copper Peptide)

Role: Collagen synthesis and tissue remodelling

• Dose: 1-2 mg
• Frequency: Once daily (evening)
• Administration: Subcutaneous injection
• Mechanism: Stimulates collagen and elastin production, reduces oxidative stress, supports wound healing

Dosing Schedule

| Day | BPC-157 | TB-500 | GHK-Cu | |-----|---------|--------|--------| | Monday | 250-500 mcg (AM/PM) | 2-5 mg | 1-2 mg (PM) | | Tuesday | 250-500 mcg (AM/PM) | - | 1-2 mg (PM) | | Wednesday | 250-500 mcg (AM/PM) | - | 1-2 mg (PM) | | Thursday | 250-500 mcg (AM/PM) | 2-5 mg | 1-2 mg (PM) | | Friday | 250-500 mcg (AM/PM) | - | 1-2 mg (PM) | | Saturday | 250-500 mcg (AM/PM) | - | 1-2 mg (PM) | | Sunday | 250-500 mcg (AM/PM) | - | 1-2 mg (PM) |

Preparation Instructions

1. Reconstitution: Add 2-3 ml bacteriostatic water to each peptide vial slowly down the side. Gently swirl, do not shake.
2. Storage: Store reconstituted peptides at 2-8°C (refrigerator). Use within 2-4 weeks.
3. Supplies: Insulin syringes (0.5-1 ml), alcohol swabs, sharps container
4. Injection Sites: Rotate sites to prevent tissue irritation. For BPC-157, inject within 5-10 cm of injury site when possible.

Administration Protocol

Week 1-2: Loading Phase

• BPC-157: 500 mcg twice daily
• TB-500: 5 mg twice weekly
• GHK-Cu: 2 mg daily

Week 3-8: Maintenance Phase

• BPC-157: 250-500 mcg twice daily (adjust based on response)
• TB-500: 2-5 mg twice weekly
• GHK-Cu: 1-2 mg daily

Monitoring & Assessment

Weekly Tracking

• Pain levels (0-10 scale)
• Range of motion (degrees or functional tests)
• Swelling and inflammation
• Functional capacity (ability to perform specific movements)

Expected Milestones

• Week 1: Reduced acute inflammation, decreased pain (20-30% improvement)
• Week 2: Improved mobility, reduced stiffness
• Week 3-4: Noticeable functional improvements, return to light activity
• Week 5-8: Continued strength gains, tissue remodelling, return to full activity

Red Flags (Stop Protocol and Consult Healthcare Provider)

• Increased pain or swelling
• Signs of infection (redness, warmth, fever)
• Allergic reactions
• Unusual bruising or bleeding

Research Evidence

BPC-157

• Over 100 animal studies demonstrating accelerated healing
• Shown to heal Achilles tendon injuries 30-40% faster in rat models
• Protects against NSAID-induced gut damage
• No lethal dose identified in toxicology studies

TB-500

• Phase 2 clinical trials for wound healing and tissue repair
• Demonstrated efficacy in cardiac tissue repair (animal models)
• Promotes hair growth and skin healing
• Well-tolerated with minimal side effects

GHK-Cu

• Extensively studied for wound healing and skin regeneration
• Increases collagen synthesis by 70% in vitro
• Reduces inflammation markers (IL-6, TNF-α)
• Improves tissue tensile strength

UK-Specific Guidance

Sourcing

Research-grade peptides can be sourced from UK-based suppliers. Verify third-party testing certificates (HPLC, mass spectrometry) before purchase.

Lab Testing

Consider baseline blood work before starting:

• Medichecks: Comprehensive health check (£89-£149)
• Thriva: Peptide safety panel (£99)
• Recommended tests: Full blood count, liver function, kidney function, inflammatory markers (CRP)

Legal Status

The MHRA classifies these peptides as research compounds. They are legal to purchase for research purposes but not approved for human therapeutic use. This protocol is for educational purposes only.

NHS Considerations

If you're receiving NHS treatment for your injury, inform your healthcare provider about any research compounds you're using. This protocol should complement, not replace, standard medical care.

Disposal

Dispose of needles and syringes in approved sharps containers available free from most UK pharmacies. Do not dispose of sharps in household waste.

Safety Considerations

Contraindications

• Active cancer (due to angiogenic properties of BPC-157 and TB-500)
• Pregnancy or breastfeeding
• History of blood clots (theoretical risk)
• Known allergies to peptides

Side Effects

Most users tolerate this protocol well. Potential side effects include:

• Injection site irritation (common, mild)
• Temporary fatigue (uncommon)
• Headache (rare)
• Nausea (rare)

Drug Interactions

No significant drug interactions reported. However, inform your healthcare provider about all medications and supplements you're taking.

Cost Estimate (UK)

| Item | Cost | |------|------| | BPC-157 (5mg x 4 vials) | £80-£120 | | TB-500 (5mg x 4 vials) | £120-£180 | | GHK-Cu (50mg x 1 vial) | £40-£60 | | Bacteriostatic water | £15-£25 | | Insulin syringes (100 pack) | £10-£15 | | Alcohol swabs | £5-£10 | | Total (8-week protocol) | £270-£410 |

Frequently Asked Questions

Can I use just one or two peptides instead of all three?

Yes, but the synergistic effect is reduced. BPC-157 alone provides significant benefits for localised injuries. Adding TB-500 enhances systemic healing. GHK-Cu is optional but supports long-term tissue remodelling.

How quickly will I see results?

Most users report reduced pain and inflammation within 7-14 days. Functional improvements typically appear by week 3-4. Complete healing depends on injury severity.

Can I continue training during this protocol?

Light activity is encouraged to promote blood flow. Avoid activities that aggravate the injury. Gradually increase intensity as healing progresses.

What happens after I finish the protocol?

Most injuries continue to improve for 2-4 weeks after stopping the protocol. Consider a maintenance phase with reduced dosing if needed for chronic conditions.

Is this protocol safe for long-term use?

These peptides have good safety profiles in research studies. However, long-term human data is limited. Cycles of 4-8 weeks with breaks are recommended.

References

1. Seiwerth S, et al. BPC 157 and blood vessels. Curr Pharm Des. 2014;20(7):1121-5.
2. Goldstein AL, et al. Thymosin beta4: a multi-functional regenerative peptide. Expert Opin Biol Ther. 2012;12(1):37-51.
3. Pickart L, et al. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108.

---

Disclaimer: This protocol is for educational and research purposes only. It is not medical advice. Consult with a qualified healthcare professional before starting any peptide protocol. These compounds are not approved by the MHRA for human therapeutic use.